x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Proactive - Interviews for investors

Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage. Here we plug you into what’s new and exciting in the world of business.

business investing

All Episodes

00:05:59

HeartCore Enterprises reports best quarter ever as Go...

Proactive - Interviews for investors ·

2024/11/15

HeartCore Enterprises Inc CEO Sumitaka Kanno talked with Proactive's Stephen Gunnion about the company’s strong third-quarter performance and future outlook. The company achieved a record-breaking $17.9 million in revenue, marking a 281% growth. Kanno highlighted that its Go IPO business, which assists Japanese companies in listing on US stock exchanges, contributed about $14 million of this revenue. The company also reported net profit of $10 million. Kanno shared updates on HeartCore’s software

en

00:03:47

Blackstone Minerals and Digbee CEOs discuss ESG...

Proactive - Interviews for investors ·

2024/11/15

Digbee CEO Jamie Strauss and Blackstone Minerals CEO Scott Williamson joined Proactive's Stephen Gunnion to discuss Blackstone Minerals' latest ESG efforts and strategic expansion. Williamson explained the role of Digbee's assessments in guiding the junior miner's ESG progress, noting that it’s a valuable tool for both internal reflection and external reporting to shareholders. “It’s all about progress and incremental small steps,” Williamson shared, adding that Digbee’s assessments allow

en

00:07:52

Alcidion Group's $1 billion impact on healthcare...

Proactive - Interviews for investors ·

2024/11/15

Alcidion Group Limited MD and CEO Kate Quirke talked with Proactive's Stephen Gunnion about how the company is making waves in healthcare innovation. Alcidion is leveraging its Miya Precision platform to address inefficiencies in healthcare delivery by improving patient outcomes and driving cost reductions. Quirke revealed that Alcidion is already having a $1 billion positive impact on healthcare spending, highlighting the effectiveness of the platform's data consolidation and augmented

en

00:07:06

GTI Energy set for resource update next month

Proactive - Interviews for investors ·

2024/11/14

GTI Energy Ltd (ASX:GTR, OTC:GTRIF) CEO Bruce Lane talked with Proactive’s Tylah Tully about the company’s progress toward delivering an updated mineral resource estimate (MRE) and exploration target for the Lo Herma ISR Uranium Project in Wyoming's Powder River Basin.Lane shared that GTI Energy remained on track to release the updated estimate next month. This will include an expansion to the exploration target following recent drilling successes in the Fort Union formation and the addition of

en

00:07:37

Inside Catapult Group’s strong performance & future...

Proactive - Interviews for investors ·

2024/11/14

Catapult Group International Ltd (ASX: CAT) CEO Will Lopes speaks with Proactive’s Tylah Tully about the company’s progress and its financial results for the first half of FY25. Lopes began by outlining Catapult’s position as a sports-focused enterprise software company serving professional teams across 40 sports and 100 countries, from the AFL to the NFL and collegiate teams in the U.S. The company has two main product areas: wearables and video analytics. Catapult’s wearable technology provides

en

00:01:42

Just the Facts: Far East Gold unveils 540,000 ounce...

Proactive - Interviews for investors ·

2024/11/14

Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Far East Gold Ltd (ASX:FEG, OTC:FEGDF). FEG has reported an initial JORC 2012 inferred mineral resource estimate of 540,000 ounces of gold at 4.1 g/t and 468,000 ounces of silver at 3.6 g/t at its Idenburg Project in Indonesia. The estimate, covering the Sua, Bermol and Mafi prospects, utilises historical drill hole data, enhanced with recent topographic surveys and revised 3D deposit modelling by SMG Consulting. These

en

00:05:05

Medicus Pharma CEO Dr Raza Bokhari on $4M Nasdaq IPO...

Proactive - Interviews for investors ·

2024/11/14

Medicus Pharma (TSX-V:MDCX, NASDAQ:MDCX) CEO and chairman Raza Bokhari speaks with Proactive's Stephen Gunnion about the company’s listing on Nasdaq, marking a key milestone for the biotechnology firm. Medicus raised $4 million through the IPO to fund its ongoing phase 2 proof-of-concept trial for a promising noninvasive treatment for basal cell carcinoma, the most common form of skin cancer. The $15 billion market for skin cancer treatments reflects a significant unmet need, and Medicus Pharma

en

00:03:59

NEXE Innovations partners with ecoBeans in Canadian...

Proactive - Interviews for investors ·

2024/11/14

NEXE Innovations president Ash Guglani talked with Proactive's Stephen Gunnion about the company’s renewed partnership with ecoBeans, a woman-led coffee brand focused on sustainability. The two companies first partnered in 2023, and ecoBeans has since rebranded, expanding its market focus on Canadian retail and additional product offerings. Guglani explained, “ecoBeans has revamped their strategy to focus more on Canadian retail, as well as some business on the West Coast.” NEXE Innovations is

en

00:07:42

Lisata Therapeutics CEO David Mazzo on Q3 results;...

Proactive - Interviews for investors ·

2024/11/14

Lisata Therapeutics Inc (NASDAQ:LSTA) CEO David Mazzo takes Proactive's Stephen Gunnion through the latest updates on the company's clinical trials and financial standing. Following the release of third-quarter results, Mazzo highlighted advancements in Lisata's pancreatic cancer program, specifically the ASCEND trial, which is expected to yield important data soon. He noted that the data from this trial’s first cohort would be presented at the upcoming American Society of Clinical Oncology (ASCO)

en

00:07:00

Aclara Resources teams with US Department of Commerce...

Proactive - Interviews for investors ·

2024/11/14

Aclara Resources Inc. chief financial officer Francois Motte talked with Proactive about the company’s collaboration with the US Department of Commerce. This partnership aims to identify an ideal location in the United States for Aclara's planned rare earth separation facility. This facility would play a key role in strengthening the US supply chain for critical minerals, addressing a strategic need for North American mineral independence. Motte emphasized the Department of Commerce’s role in

en

00:06:31

Happy Creek Minerals unveils 10,000m 2025-2026...

Proactive - Interviews for investors ·

2024/11/14

Happy Creek Minerals Ltd. (TSX-V:HPY, OTC:HPYCF) CEO Jason Bahnsen talked with Proactive about an upcoming 10,000-meter exploration drilling program at the company’s Fox tungsten project in British Columbia’s South Cariboo district, with drilling expected to start in 2025. Bahnsen highlighted that the Fox project, covering 139 square kilometers, contains one of North America’s highest-grade tungsten deposits, with initial resources reported in 2018 totaling around one million tons at approximately

en

00:02:58

Helix Exploration Reaches total depth in Darwin #1...

Proactive - Interviews for investors ·

2024/11/14

Helix Exploration CEO Bo Sears joined Steve Darling from Proactive to announce the completion of the Darwin #1 well drilling at the Rudyard project area in Montana, where they reached a total depth of 5,488 feet within 12 days. Initial assessments showed promising helium gas-shows across multiple horizons, with concentrations reaching up to 1,312 ppm in drilling mud. Over 330 feet of potential gross pay was identified, including untapped formations not covered in historic drilling. The results

en

00:05:11

Chemomab Therapeutics CEO Dr Adi Mor discusses Q3...

Proactive - Interviews for investors ·

2024/11/14

Chemomab Therapeutics CEO Dr Adi Mor talked with Proactive's Stephen Gunnion about recent advancements in Chemomab's mission to treat rare fibrotic diseases, focusing on primary sclerosing cholangitis (PSC). Following the release of the company's third-quarter results, Mor shared that Chemomab’s lead candidate, CM-101, a drug targeting inflammation and fibrosis, recently delivered positive topline results in a Phase 2 clinical trial. “We are targeting rare diseases with large commercial potential

en

00:04:17

Far East Gold delivers maiden 540,000-ounce resource...

Proactive - Interviews for investors ·

2024/11/14

Far East Gold Ltd (ASX:FEG, OTC:FEGDF). CEO Shane Menere joins Proactive’s Tylah Tully to discuss the company’s latest milestone.It has delivered an initial JORC 2012 inferred mineral resource estimate of 540,000 ounces of gold at 4.1 g/t and 468,000 ounces of silver at 3.6 g/t at its Idenburg Project in Papua, Indonesia. This estimate, based on just three prospects within the Idenburg Contract of Work was developed by SMG Consulting using historical drill hole data and new topographic survey

en

00:07:29

Inside Scout Security’s strategic Roo acquisition

Proactive - Interviews for investors ·

2024/11/14

Scout Security Ltd (ASX:SCT) CEO and executive director Ryan McCall talks with Proactive’s Tylah Tully about the company’s latest strategic move: a merger with Roo Inc., a fellow DIY home security company.McCall outlined the mutual benefits of this merger, which will combine the companies’ strengths in the DIY security and smart home markets, enhancing scale and efficiency. Scout Security, initially a direct-to-consumer business, has pivoted toward white-label partnerships, delivering custom

en

00:15:36

Groundbreaking cancer trial: Imugene’s CF33 advances...

Proactive - Interviews for investors ·

2024/11/13

Imugene Ltd (ASX:IMU, OTC:IUGNF) CEO Leslie Chong and Professor Yuman Fong, chair of the Department of Surgery at the City of Hope and strategic advisor to Imugene, spoke with Proactive’s Tylah Tully about the latest developments in Imugene’s CF33 MAST (Metastatic Advanced Solid Tumours) VAXINIA study. Professor Fong, the inventor of CF33, described the approach behind the therapy, where genetically engineered viruses are designed to infect and kill cancer cells without harming normal cells. “In

en

00:01:52

Just the Facts: Astral Resources reveals gold grades...

Proactive - Interviews for investors ·

2024/11/13

Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Astral Resources NL (ASX:AAR). The company has received high-grade gold intercepts from the final 11 drill holes at its Kamperman Deposit, part of the Feysville Gold Project in Western Australia. The reverse circulation (RC) drilling campaign comprised 31 holes, revealing significant gold intersections that reinforce the site’s resource potential. Key results include an intercept of 6 metres at 12.8 g/t gold from 76

en

00:08:06

Navarre Minerals resumes ASX trading with gold focus

Proactive - Interviews for investors ·

2024/11/13

Navarre Minerals Ltd (ASX:NML) managing director and executive chair James Gurry talks with Proactive’s Tylah Tully about the company's recent recapitalisation, ASX trading resumption and its renewed focus on high-grade gold exploration in Victoria. Following a strategic shift back to its core gold exploration roots, Navarre now prioritises advanced exploration across five primary projects, including the Tandarra, Irvine and St Arnaud projects. Gurry highlighted Navarre’s resource potential,

en

00:08:04

Everything you need to know about AGM season: Jane...

Proactive - Interviews for investors ·

2024/11/13

IR Department’s managing director Jane Lowe talked with Proactive’s Tylah Tully about AGM season and the critical role annual general meetings play for shareholders and companies alike. Lowe highlighted the importance of AGMs as a platform for shareholder engagement, noting they offer shareholders a rare chance to vote on essential company matters and interact directly with the board and executive team. “The AGM can be an excellent platform for engaging with potential and existing shareholders,”

en

00:06:26

Empire Metals has breakthrough titanium results at...

Proactive - Interviews for investors ·

2024/11/13

Empire Metals Ltd (LON:EEE) managing director Shaun Bunn talked with Proactive’s Tylah Tully about metallurgical results from the Pitfield Titaniujm Project in Western Australia. Gravity and flotation test results show that Empire can successfully separate titanium minerals from other gangue materials, reducing potential downstream processing costs. "Simple gravity separation is getting rid of the silicates," Bunn noted, explaining the advantage of reducing complexities and costs in further

en

4,496 results

Similar Podcasts

TaxTalent.com The Golden Rule Podcast

Adam Golden

TaxTalent.com Podcast

Tony Santiago

Handelsblatt Crime - spannende Streitfälle der deutschen Wirtschaft

Ina Karabasz, Solveig Gode, Sönke Iwersen

Deffner und Zschäpitz – Der Wirtschafts-Talk von WELT

WELT

Black Box - La scatola nera della finanza

Guido Brera e Gian Luca Comandini -...